<?xml version="1.0" encoding="UTF-8"?>
<p id="Par75">hAdV infections in HSCT recipients and in other severely immunocompromised hosts may be the consequence of new contact with the virus or the reactivation of endogenous infections [
 <xref ref-type="bibr" rid="CR6">6</xref>]. In immunocompromised and HSCT pediatric recipients, hAdV is associated with severe complications and mortality. hAdV infections are less common in adult patients (incidence range: 1â€“30%) [
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR11">11</xref>].
</p>
